Fintiv Rule Challenges Face Long Odds After Fed. Circ. Ruling

Tuesday, March 16, 2021

Keri Schaubert was quoted in Law360 discussing how technology companies and generic-drug makers have said the policy, known as the NHK-Fintiv rule after the PTAB rulings that established it, unfairly restricts the ability to seek inter partes review of patents under the America Invents Act. The appeals court "basically closed the door to appealing a denial of an institution of an IPR on the basis of the Fintiv rule," said Keri.

To read more of this article, click here.

Share on LinkedIn


Related Practice Areas

Keep up-to-date with the latest news from Cozen O'Connor

Enter your City or Zip.

Probably shouldn't change this:
Sign up to receive alerts, publications, and event / webinar invites.

By submitting your contact information, you are giving Cozen O'Connor consent to contact you via email.